Glycogen hepatopathy is the pathological overloading of hepatocytes with glycogen that is associated with poorly controlled diabetes mellitus. Clinically, it presents with abdominal discomfort, tender hepatomegaly and elevated transaminases. In this report, we describe our experience with two cases of type I diabetes mellitus and glycogen hepatopathy. The patients underwent isolated pancreas transplantation, following which, we have been able to demonstrate complete histological resolution of glycogen hepatopathy associated with control of glucose metabolism.
G lycogen hepatopathy (GH) has been characterized as a pathologic overloading of hepatocytes with glycogen that is associated with poorly controlled type 1 diabetes mellitus. Clinically, it presents with a spectrum of clinical signs and symptoms, including abdominal discomfort, tender hepatomegaly, and elevated transaminases. We have recently treated two patients with GH who presented with tender hepatomegaly and elevated liver chemistries. Pancreas transplantation was indicated as a result of the difficulty in controlling the underlying diabetes and frequent episodes of hypoglycemic unawareness in both cases. Liver biopsies before and five to six months after transplantation were obtained. The two cases showed remarkable improvement in clinical features and dramatic resolution of the liver pathology associated with normalization of serum glucose levels after pancreas transplantation.
History and Examination
Case no. 1 This patient was an 18-year-old woman at the time of pancreas transplantation. She was diagnosed with type 1 diabetes mellitus at seven years old. Her course was complicated by poor glycemic control requiring multiple hospital admissions for diabetic ketoacidosis and hypoglycemic unawareness. She had no known diabetic neuropathy, retinopathy, or nephropathy. She had constant abdominal pain associated with tender hepatomegaly. Laboratory investigation demonstrated mild elevation in transaminases with normal bilirubin. Screening for other liver diseases excluded viral and autoimmune hepatitis as well as inherited metabolic diseases. Radiologic evaluation demonstrated hepatomegaly on computed tomography scan and increased echogenic texture of the liver on ultrasound. She was evaluated and listed for isolated pancreas transplantation on the basis of her poor diabetic control and frequent hospitalizations.
Case no. 2
This patient was a 21 year-old man at the time of pancreas transplantation. He was diagnosed with type 1 diabetes mellitus at eight years of age. His course was complicated by poor glucose control and two intensive care unit admissions for diabetic coma after undetected hypoglycemic episodes. He had no evidence of diabetic nephropathy, neuropathy, or retinopathy. He had marked hepatomegaly with elevated transaminases and alkaline phosphatase, but with normal bilirubin. Workup for viral and autoimmune hepatitis and metabolic liver diseases was negative. He was listed for isolated pancreas transplantation based on his history of hypoglycemic unawareness.
In both cases, the transplant was performed through a midline incision with systemic venous drainage and enteric exocrine drainage. Immunosuppression included induction with rabbit anti-thymocyte globulin followed by early steroid withdrawal and maintenance therapy with tacrolimus, sirolimus, and low-dose mycophenolate mofetil. Hepatomegaly completely resolved and liver chemistries normalized. Liver biopsies were obtained at transplantation as well as 8 to 12 months after pancreas transplantation.
The initial liver biopsies taken at the time of transplantation were virtually identical in both patients. The parenchymal architecture of the liver was preserved, the portal tracts were unremarkable, and the biopsies had a very pale appearance (Fig. 1A ). Examination at a higher power magnification showed that the pallor was the result of diffusely swollen hepatocytes with pale cytoplasm that had a faintly eosinophilic and vaguely ground glass appearance. Intracellular vesicles, easily identified giant mitochondria (Fig. 1B) , and numerous glycogenated nuclei were seen (Fig. 1B, inset) . Fatty changes and sinusoidal fibrosis typically seen with steatohepatitis were not present. A periodic acid-Schiff stain with and without diastase digestion showed extensive glycogen deposition throughout the parenchyma. The follow-up biopsies demonstrated complete resolution of the pale glycogen-rich cytoplasm, giant mitochondria, and glycogenated nuclei (Fig. 1C, D) .
DISCUSSION AND CONCLUSIONS
We have reported two cases of GH in young diabetic patients with poor glycemic control with complete clinical and pathologic resolution after pancreas transplantation. Glycogen loading of the liver is seen in patients with poorly controlled insulin-dependent diabetes mellitus and may cause tender hepatomegaly, abdominal discomfort, and elevated transaminases. Normalization of glucose metabolism in these patients after pancreas transplantation is accompanied by disappearance of accumulated glycogen from the liver. In 1930, Mauriac described a syndrome of glycogen loading, hepatomegaly, and abnormal liver enzymes associated with growth retardation and/or dwarfism, delayed puberty, cushingoid features, and hypercholesterolemia (1). It has since been recognized that glycogen loading and hepatic disease may be present in the absence of the extrahepatic manifestations described earlier by Mauriac (2) . This process has variably been referred to as hepatic glycogenosis (3), liver glycogenosis (4), liver glycogen storage (5, 6) , diabetes mellitus-associated glycogen storage hepatomegaly (7), and most recently glycogenic hepatopathy (8) .
Although GH has been described several times over the years in the medical literature, the condition often goes underrecognized by clinicians, radiologists, and pathologists. This is a reflection of the rarity of GH coupled with the common occurrence of fatty liver disease; a patient with hepatomegaly and elevated transaminases is therefore assumed to have fatty liver unless a biopsy is obtained. Furthermore, ultrasound does not distinguish fatty liver from glycogen overload (3) (4) (5) 8) .
A liver biopsy provides definitive diagnosis by first excluding the presence of fat and second by the distinctive histologic features of GH. The liver biopsy shows pale, swollen hepatocytes resulting from marked glycogen accumulation, giant mitochondria, intracellular vesicles, and glycogenated nuclei. There is usually no fibrosis so that the parenchymal architecture is intact. There is minimal, if any, inflammation or lobular necrosis even when the transaminases are markedly elevated. The enzyme elevation is thought to reflect hepatocyte injury causing enzyme leakage rather than actual cell death. We believe that a similar mechanism of enzyme leakage resulting from marked accumulation of hepatocellular glycogen causes the transient elevations in liver transaminases after insulin loading in the treatment of diabetic ketoacidosis (9, 10) . In GH, liver transaminases, even when markedly elevated, typically return to normal with adequate control of blood sugar levels (3, 4, (11) (12) (13) . We have additionally demonstrated that histologic resolution accompanies the normalization of carbohydrate metabolism.
Pancreas transplantation is performed to induce an insulin-independent, euglycemic state in patients with diabetes. The procedure is most frequently performed in those patients with severe secondary complications of diabetes, including kidney failure, who would therefore be immunosuppressed for a simultaneous or previous renal transplant for diabetic nephropathy. Increasingly, however, pancreas transplantation is offered to patients with labile diabetes or those with potentially lethal complications of diabetes such as hypoglycemic unawareness. Although it is unlikely that the presence of GH in a diabetic patient would be considered an indication for isolated pancreas transplant if it were the patient's only complication, it may help make a decision to proceed with transplantation in a borderline case, because the patient would have the added benefit of symptomatic relief and normalization of hepatic pathology. 
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